Post-stroke depression

From WikiMD's Medical Encyclopedia

Revision as of 12:50, 12 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Post-stroke depression
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Depression (mood), anhedonia, fatigue (medical), anxiety, irritability
Complications Decreased quality of life, increased mortality, poor rehabilitation outcomes
Onset Typically within 3 months post-stroke
Duration Can be chronic
Types N/A
Causes Cerebrovascular accident, biochemical changes, psychosocial factors
Risks History of depression, severity of stroke, social isolation
Diagnosis Clinical assessment, screening tools like PHQ-9
Differential diagnosis Adjustment disorder, bipolar disorder, dementia
Prevention N/A
Treatment Antidepressants, psychotherapy, rehabilitation
Medication Selective serotonin reuptake inhibitors, tricyclic antidepressants
Prognosis Variable; depends on treatment and individual factors
Frequency Affects approximately 30% of stroke survivors
Deaths N/A


Post-stroke depression (PSD) is a common and serious complication that can occur after a stroke. It is characterized by a persistent feeling of sadness, loss of interest in activities, and other symptoms of depression that occur after a cerebrovascular event. PSD can significantly affect the recovery and quality of life of stroke survivors.

Epidemiology[edit]

Post-stroke depression affects approximately one-third of all stroke survivors. The incidence of PSD can vary depending on the population studied and the methods used to diagnose depression. It is more common in patients with a history of depression or other psychiatric disorders.

Pathophysiology[edit]

The exact mechanisms underlying post-stroke depression are not fully understood. However, it is believed to be related to both biological and psychological factors. The location and severity of the stroke, particularly in the middle cerebral artery (MCA) territory, can influence the likelihood of developing PSD. Biological factors may include changes in neurotransmitter levels, inflammation, and alterations in brain connectivity. Psychological factors may involve the emotional response to the disability and lifestyle changes following a stroke.

Clinical Features[edit]

Symptoms of post-stroke depression can include:

  • Persistent sadness or low mood
  • Loss of interest or pleasure in activities
  • Changes in appetite or weight
  • Sleep disturbances
  • Fatigue or loss of energy
  • Feelings of worthlessness or guilt
  • Difficulty concentrating
  • Thoughts of death or suicide

Diagnosis[edit]

The diagnosis of post-stroke depression is typically made based on clinical assessment. Healthcare providers may use standardized screening tools such as the Patient Health Questionnaire (PHQ-9) or the Hamilton Depression Rating Scale to aid in diagnosis.

Treatment[edit]

Treatment for post-stroke depression may include a combination of pharmacological and non-pharmacological approaches. Antidepressant medications, such as selective serotonin reuptake inhibitors (SSRIs), are commonly used. Psychotherapy, including cognitive behavioral therapy (CBT), can also be effective.

Prognosis[edit]

The prognosis for individuals with post-stroke depression varies. Early diagnosis and treatment are crucial for improving outcomes. Untreated PSD can lead to poorer recovery, increased disability, and a higher risk of mortality.

Prevention[edit]

Preventive strategies for post-stroke depression may include early screening for depressive symptoms, providing psychological support, and addressing modifiable risk factors such as hypertension and diabetes.

See also[edit]





Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.